Blueprint Investment Partners LLC decreased its holdings in shares of The Procter & Gamble Company (NYSE:PG - Free Report) by 22.0% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 11,469 shares of the company's stock after selling 3,227 shares during the period. Blueprint Investment Partners LLC's holdings in Procter & Gamble were worth $1,923,000 at the end of the most recent reporting period.
A number of other large investors have also modified their holdings of the business. NewSquare Capital LLC grew its holdings in Procter & Gamble by 933.3% in the 4th quarter. NewSquare Capital LLC now owns 155 shares of the company's stock valued at $26,000 after buying an additional 140 shares during the period. RPg Family Wealth Advisory LLC acquired a new position in Procter & Gamble in the third quarter worth about $33,000. LFA Lugano Financial Advisors SA bought a new stake in Procter & Gamble in the fourth quarter valued at about $34,000. Atlantic Private Wealth LLC raised its stake in Procter & Gamble by 95.3% during the fourth quarter. Atlantic Private Wealth LLC now owns 207 shares of the company's stock valued at $35,000 after buying an additional 101 shares in the last quarter. Finally, Noble Wealth Management PBC bought a new position in Procter & Gamble during the 4th quarter worth approximately $39,000. 65.77% of the stock is owned by hedge funds and other institutional investors.
Procter & Gamble Stock Down 1.8 %
NYSE PG traded down $3.00 during trading on Tuesday, hitting $162.65. 2,848,541 shares of the company traded hands, compared to its average volume of 6,476,854. The Procter & Gamble Company has a 12 month low of $153.52 and a 12 month high of $180.43. The company has a market capitalization of $381.39 billion, a P/E ratio of 25.89, a PEG ratio of 3.76 and a beta of 0.41. The company has a current ratio of 0.76, a quick ratio of 0.55 and a debt-to-equity ratio of 0.50. The business has a fifty day simple moving average of $168.11 and a 200 day simple moving average of $169.58.
Procter & Gamble (NYSE:PG - Get Free Report) last announced its quarterly earnings results on Wednesday, January 22nd. The company reported $1.88 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.86 by $0.02. Procter & Gamble had a net margin of 18.35% and a return on equity of 33.00%. The firm had revenue of $21.88 billion for the quarter, compared to analyst estimates of $21.66 billion. During the same quarter in the previous year, the firm posted $1.84 EPS. The business's revenue for the quarter was up 2.1% on a year-over-year basis. As a group, sell-side analysts predict that The Procter & Gamble Company will post 6.91 EPS for the current year.
Procter & Gamble Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Tuesday, February 18th. Stockholders of record on Friday, January 24th were given a dividend of $1.0065 per share. The ex-dividend date of this dividend was Friday, January 24th. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.48%. Procter & Gamble's dividend payout ratio is 64.01%.
Insiders Place Their Bets
In related news, CEO Gary A. Coombe sold 18,000 shares of the firm's stock in a transaction dated Tuesday, February 25th. The shares were sold at an average price of $171.66, for a total value of $3,089,880.00. Following the completion of the sale, the chief executive officer now directly owns 22,051 shares in the company, valued at approximately $3,785,274.66. This trade represents a 44.94 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Marc S. Pritchard sold 90,450 shares of the stock in a transaction dated Thursday, January 23rd. The shares were sold at an average price of $163.84, for a total transaction of $14,819,328.00. Following the completion of the transaction, the insider now directly owns 172,814 shares in the company, valued at $28,313,845.76. The trade was a 34.36 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 143,450 shares of company stock worth $23,988,008 over the last ninety days. 0.18% of the stock is currently owned by corporate insiders.
Wall Street Analyst Weigh In
PG has been the topic of a number of research reports. Barclays increased their target price on shares of Procter & Gamble from $155.00 to $159.00 and gave the stock an "equal weight" rating in a report on Thursday, January 23rd. JPMorgan Chase & Co. lowered their price target on shares of Procter & Gamble from $186.00 to $181.00 and set an "overweight" rating for the company in a research report on Thursday, January 16th. UBS Group restated a "buy" rating on shares of Procter & Gamble in a research note on Monday, February 10th. Piper Sandler decreased their price objective on shares of Procter & Gamble from $173.00 to $172.00 and set a "neutral" rating for the company in a report on Monday, February 24th. Finally, Royal Bank of Canada reissued a "sector perform" rating and set a $164.00 target price on shares of Procter & Gamble in a report on Thursday, January 23rd. Seven research analysts have rated the stock with a hold rating, twelve have given a buy rating and three have issued a strong buy rating to the stock. Based on data from MarketBeat, Procter & Gamble presently has an average rating of "Moderate Buy" and a consensus target price of $181.47.
Check Out Our Latest Stock Report on Procter & Gamble
About Procter & Gamble
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Further Reading

Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.